Allen Brain Institute to Use ISH in Lou Gehrig Disease Markers Search | GenomeWeb
NEW YORK (GenomeWeb News) – The Allen Institute for Brain Science will perform in situ hybridization services on tissues for the ALS Therapy Development Institute (ALS TDI) to help identify cells linked to gene expression with the hope of developing treatments for amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease, ALS TDI said today.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.